SERVICES PROVIDED TO LYMPHOMA PATIENTS, THEIR FAMILIES AND FRIENDS AND THE GENERAL PUBLIC CONCERNING INFORMATION RECEIVED FROM PHARMACEUTICAL AND BIOTECHNICAL ORGANIZATIONS AND MEDICAL INSTITUTIONS, INCLUDING THE NATIONAL CANCER INSTITUTE, RELATING TO LYPHOMA, CLINICAL TRIALS, RESEARCH AND OTHER LYMPHOMA-SPECIFIC INFORMATION

'biotechn':20 'cancer':28 'clinic':33 'concern':14 'famili':7 'friend':9 'general':12 'includ':25 'inform':15,41 'institut':24,29 'lymphoma':4,39 'lymphoma-specif':38 'lyphoma':32 'medic':23 'nation':27 'organ':21 'patient':5 'pharmaceut':18 'provid':2 'public':13 'receiv':16 'relat':30 'research':35 'servic':1 'specif':40 'trial':34

FAMILIES AND FRIENDS AND THE GENERAL PUBLIC INFORMATION RECEIVED FROM PHARMACEUTICAL AND BIOTECHNOLOGICAL ORGANIZATIONS AND MEDICAL INSTITUTIONS, INCLUDING THE NATIONAL CANCER INSTITUTE, RELATING TO LYMPHOMA, CLINICAL TRIALS, RESEARCH AND OTHER LYMPHOMA-SPECIFIC INFORMATION

'biotechnolog':13 'cancer':21 'clinic':26 'famili':1 'friend':3 'general':6 'includ':18 'inform':8,34 'institut':17,22 'lymphoma':25,32 'lymphoma-specif':31 'medic':16 'nation':20 'organ':14 'pharmaceut':11 'public':7 'receiv':9 'relat':23 'research':28 'specif':33 'trial':27

LYMPHOMA NEWSLINE

Owner

Goods & Services